WRUR 88.5 Different Radio

James Doubek

James Doubek is an associate editor and reporter for NPR. He frequently covers breaking news for NPR.org and NPR's hourly newscast. In 2018, he reported feature stories for NPR's business desk on topics including electric scooters, cryptocurrency, and small business owners who lost out when Amazon made a deal with Apple.

In the fall of that year, Doubek was selected for NPR's internal enrichment rotation to work as an audio producer for Weekend Edition. He spent two months pitching, producing, and editing interviews and pieces for broadcast.

As an associate producer for NPR's digital content team, Doubek edits online stories and manages NPR's website and social media presence.

He got his start at NPR as an intern at the Washington Desk, where he made frequent trips to the Supreme Court and reported on political campaigns.

Dr. Anthony Fauci, the country's foremost infectious disease expert, tells NPR that it's "OK to celebrate" the good news about Moderna's coronavirus vaccine, but warned it's not the time to back off on basic health measures.

The biotechnology Moderna Inc. said Monday that its experimental vaccine was 94.5% effective in preventing the disease, according to data from its clinical trial.

Iowa is one of several states, mostly in the Midwest, where coronavirus cases in nursing homes are rising faster than in nursing homes nationally.

While national cases in nursing home residents and staff rose by 8% between September and October, the numbers in Iowa more than doubled in that time, according to the AARP.

After a purge at the Pentagon, former national security officials are worried about the fallout if President Trump were to launch an unprovoked military action against Iran or make big changes in Afghanistan in his waning days in office.

That's in addition to the ways that President Trump's refusal to concede and to give President-elect Biden access to intelligence materials are already damaging national security.

Despite Joe Biden's victory, congressional Democrats are upset.

Bolstered by President Trump's unpopularity and the pandemic, polls had showed Democrats possibly taking control of the Senate, expanding their majority in the House of Representatives and Biden winning convincingly in several swing states.

But Democrats didn't gain a majority in the Senate. They lost a handful of seats in the House. And though Biden won the popular vote, it was a close contest in several battleground states.

It took Wisconsin more than seven months to reach 100,000 coronavirus cases. On Monday, just five weeks later, it reached 200,000.

Indian Americans — a small but possibly pivotal voting bloc — are overwhelmingly voting for Joe Biden this election, according to a new survey.

Both Joe Biden and President Trump's campaigns have been courting Indian American voters this year. Indian Americans are about 1% of the U.S. population and make up .82% of all eligible voters in the U.S. — but are large enough in numbers to make a decisive difference in certain swing states.

Coronavirus cases appear headed for a new surge in the U.S., which could eclipse the explosion of cases in July.

Much of the new surge is driven by cases in the Midwest and Great Plains states.

Dr. Francis Collins, director of the National Institutes of Health, says "it was all sadly somewhat predictable."

Senate Republicans plan to move forward with Judge Amy Coney Barrett's Supreme Court nomination with hearings before the Judiciary Committee starting Oct. 12.

Barrett's likely confirmation will lock in arguably the most conservative Supreme Court since the 1930s, with the potential to weaken patient protections of the Affordable Care Act and abortion rights in Roe v. Wade, among other decisions.

Novavax, a vaccine maker in Maryland, is becoming the 10th coronavirus vaccine candidate to enter the final phase of testing, called phase 3.

The trial is taking place in the U.K., where researchers plan to enroll up to 10,000 adults of various ages in the next four to six weeks. Half the participants will get a placebo and half will get the company's vaccine.

At least a quarter of participants will be over the age of 65, the company says, and it will also "prioritize groups that are most affected by COVID-19, including racial and ethnic minorities."

As of now, both the Centers for Disease Control and Prevention and World Health Organization say the primary way the coronavirus spreads is by hitching a ride on respiratory droplets when people are in close contact.

Respiratory droplets form when someone sneezes, coughs, talks or sings, for example. They don't travel far and fall to the ground quickly.

Pages